This study investigates how the HIV inhibitor lenacapavir influences capsid mechanics and interactions with the nuclear pore complex. It provides important insights into how drug-induced ...

Today, we confront emerging threats from a range of respiratory viruses, insect-transmitted viruses, and viruses we have not ...

Earlier this month, on World AIDS Day, Dec. 1, 2025, scientists published a paper in the journal “Nature” detailing the ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

Discover the powerful health benefits of Phyllanthus amarus. Learn about this traditional medicinal plant's uses for liver, ...

In a study published in Nature Ecology and Evolution, scientists show that the SAMD9 and SAMD9L genes, key players in antiviral immunity in humans and involved in rare genetic diseases, share ...

Scientists have confirmed the tenth person in the world to be in long-term HIV remission without depending on antiretroviral medication. According to a report published in Nature, the patient received ...

A research group has demonstrated that overexpression of Cdc10-dependent transcript 1 (CDT1), a key regulator of DNA ...

The 2025 Annual Report from the Basic Sciences Division at Fred Hutch features the divisions reflections for the year, as ...

Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...

CBSE Class 12 Biology Pre Board Sample Paper 2025-26 with Solution PDF is available here for exam preparation. Download PDF, as the exam will be held on 27 March 2026.

BOAS is a platform for building multivalent viral protein immunogens without a scaffold, such as a nanoparticle, to elicit broad influenza vaccine responses.